The coagulopathy underlying rotational thromboelastometry derangements in trauma patients: a prospective observational multicenter study

血栓弹性测定 医学 凝血病 纤溶 凝结 血栓造影术 混凝试验 凝血时间 纤维蛋白原 前瞻性队列研究 麻醉 内科学
作者
Romein W G Dujardin,Derek J B Kleinveld,Christine Gaarder,Karim Brohi,Ross A Davenport,Nicola Curry,Simon Stanworth,Pär I Johansson,Jakob Stensballe,Marc Maegele,Nicole P Juffermans
出处
期刊:Anesthesiology [Lippincott Williams & Wilkins]
标识
DOI:10.1097/aln.0000000000004268
摘要

Background Viscoelastic hemostatic assays such as rotational thromboelastometry (ROTEM®) are used to guide treatment of trauma induced coagulopathy. We hypothesized that ROTEM derangements reflect specific coagulation factor deficiencies after trauma. Methods Secondary analysis of a prospective cohort study in six European trauma centers in patients presenting with full trauma team activation. Patients with dilutional coagulopathy and patients on anticoagulants were excluded. Blood was drawn on arrival for measurement of ROTEM®, coagulation factor levels and markers of fibrinolysis. ROTEM® cut-off values to define hypocoagulability were: EXTEM clotting time (CT) >80s, EXTEM clot amplitude after 5 minutes (CA5) <40mm, EXTEM lysis at 30 minutes (Li30) <85%, FIBTEM clot amplitude after 5 minutes (CA5) <10mm and FIBTEM lysis at 30 minutes (Li30) <85%. Based on these, patients were divided into 7 deranged ROTEM® profiles and compared to the reference group (ROTEM® values within reference range). The primary endpoint was coagulation factors levels and fibrinolysis. Results Of 1828 patients, 40% had ROTEM® derangements 40.0%, most often consisting of a combined decrease in EXTEM and FIBTEM CA5, that was present in 217 (11.9%) patients. While an isolated EXTEM CT>80s had no impact on mortality, all other ROTEM® derangements were associated with increased mortality. Also, coagulation factor levels in this group were similar to patients with a normal ROTEM®. Of coagulation factors, decrease was most apparent for fibrinogen (with a nadir of 0.78 g/L) and for factor V levels (with a nadir of 22.8%). In addition, increased fibrinolysis can be present when LI30 is normal but EXTEM and FIBTEM CA5 is decreased Conclusion Coagulation factor levels and mortality in the group with an isolated clotting time prolongation is similar to patients with a normal ROTEM ®. Other ROTEM ® derangements are associated with mortality and reflect a depletion of fibrinogen and factor V. Increased fibrinolysis can be present when lysis after 30 minutes is normal.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Akim应助qing采纳,获得10
1秒前
失眠依珊完成签到,获得积分10
2秒前
liuchch发布了新的文献求助30
4秒前
阳光的雪珊完成签到 ,获得积分10
4秒前
4秒前
弧线完成签到,获得积分10
5秒前
着急的千山完成签到 ,获得积分10
6秒前
王一g完成签到,获得积分10
6秒前
7秒前
Orange应助青铜伤疤采纳,获得10
8秒前
8秒前
弧线发布了新的文献求助10
8秒前
烟花应助陌桑吖采纳,获得10
9秒前
可爱谷丝完成签到 ,获得积分10
9秒前
hcxhch完成签到,获得积分10
9秒前
Lucas应助健忘又夏采纳,获得10
9秒前
123完成签到,获得积分10
10秒前
小海完成签到,获得积分20
12秒前
黄飚完成签到,获得积分10
12秒前
橘子树完成签到,获得积分10
12秒前
旺旺发布了新的文献求助10
12秒前
coco完成签到,获得积分10
14秒前
郎谋发布了新的文献求助10
15秒前
15秒前
16秒前
CipherSage应助11122采纳,获得10
17秒前
20秒前
李雨蒙发布了新的文献求助10
21秒前
科研通AI6.1应助自然如冰采纳,获得10
23秒前
会飞的小甘蔗完成签到 ,获得积分10
23秒前
25秒前
臧德进123发布了新的文献求助10
25秒前
自觉的绮烟完成签到,获得积分10
26秒前
liuchch完成签到,获得积分20
26秒前
英俊的铭应助Deepsleep采纳,获得10
29秒前
舒心乘风发布了新的文献求助10
29秒前
四面八方来钱完成签到 ,获得积分10
35秒前
38秒前
Khan完成签到,获得积分20
38秒前
汉卿完成签到,获得积分10
38秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
PowerCascade: A Synthetic Dataset for Cascading Failure Analysis in Power Systems 2000
Picture this! Including first nations fiction picture books in school library collections 1500
Signals, Systems, and Signal Processing 610
Unlocking Chemical Thinking: Reimagining Chemistry Teaching and Learning 555
Photodetectors: From Ultraviolet to Infrared 500
Cancer Targets: Novel Therapies and Emerging Research Directions (Part 1) 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6359503
求助须知:如何正确求助?哪些是违规求助? 8173510
关于积分的说明 17214610
捐赠科研通 5414555
什么是DOI,文献DOI怎么找? 2865497
邀请新用户注册赠送积分活动 1842839
关于科研通互助平台的介绍 1691052